Exascale Labs Holdings Inc. (XLAB) stock forecast & analysis
1.36
NasdaqGM · USDDelayed by 15 minutes
Up: +0.45, +49.7%
1 analysis
Latest analysis: · verdict locked
- Open
- 0.8564
- Previous close
- 0.9085
- Day range
- 0.7777 – 1.45
- 52-week range
- 0.7777 – 11.17
- Volume (shares)
- 13.90M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 33.69M
- P/E ratio
- Not available
- Dividend yield
- 0.00%
- Beta
- Not available
- Market cap
- 87.50M
Market Scanner’s AI analysis of Exascale Labs Holdings Inc. (XLAB), updated October 2026: XLAB's Nasdaq listing and strategic partnerships contrasted with significant price depreciation and negative profitability.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of Exascale Labs Holdings Inc. (XLAB) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
XLAB's Nasdaq listing and strategic partnerships contrasted with significant price depreciation and negative profitability.
Recent analyses for XLAB covered its recent Nasdaq listing and strategic partnerships, alongside its significant year-over-year revenue growth. However, the reports also noted the stock's substantial price depreciation over longer periods and its current negative profit margins and earnings per share.
XLAB news & sentiment
News reports highlighted positive developments including a Nasdaq listing and strategic partnerships, alongside strong revenue growth. Social media discussion was not covered in the provided notes.
XLAB technical picture
XLAB's price action showed significant recent gains over 7 days, but substantial depreciation over 30 and 91 days. The stock traded well below its 50-day and 200-day SMAs, with short-term momentum slightly positive per the 10-day EMA. RSI approached oversold levels, while MFI indicated strong buying pressure, contrasting with bearish momentum shown by the MACD.
Fundamentals
The company XLAB reported significant year-over-year quarterly revenue growth, alongside a substantial increase in revenue from the prior fiscal year. However, analyses also noted negative profit margins and earnings per share, alongside a decrease in cash and cash equivalents.
Factors discussed — upside
- Year-over-year quarterly revenue growth of 67.8%
- Successful Nasdaq listing and commencement of trading
- Letter of Intent with Compal for data-center validation platform
- Memorandum of Understanding with EnergyBank for AI compute leveraging offshore wind
Factors discussed — risks
- Price trading significantly below 50-day and 200-day SMAs
- Negative profit margin of -82.1%
- Negative Earnings Per Share (EPS) of -$0.19
- Substantial 30-day and 91-day price depreciation
- Market Listing and Capital Access
- Strategic Partnerships
- Revenue Growth
- Profitability and Valuation
Summary updated .
XLAB technical indicators
Common technical indicators for XLAB, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 3.53 | Price below |
| 10-day exponential moving average | 1.25 | Price above |
| Relative strength index (14-day) | 31.86 | Neutral |
| MACD line (12/26/9) | -0.7969 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 0.29 – 3.22 | Price inside the bands |
Analyses
Recent XLAB.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-10-16 XLAB.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for Exascale Labs Holdings Inc.?
- The bull case for XLAB centers on its recent Nasdaq listing and strategic partnerships, including a Letter of Intent with Compal for a data-center validation platform and an MOU with EnergyBank for AI compute. These developments are supported by significant year-over-year revenue growth.
- What are the risks for Exascale Labs Holdings Inc.?
- Risks for XLAB include the stock trading significantly below its 50-day and 200-day moving averages, substantial price depreciation over the last 30 and 91 days, a negative profit margin, and negative earnings per share.
- Is Exascale Labs Holdings Inc. bullish or bearish?
- Recent AI analyses of Exascale Labs Holdings Inc. examined factors on both sides. Discussed upside: The bull case for XLAB centers on its recent Nasdaq listing and strategic partnerships, including a Letter of Intent with Compal for a data-center validation platform and an MOU with EnergyBank for AI compute. These developments are supported by significant year-over-year revenue growth. Discussed risks: Risks for XLAB include the stock trading significantly below its 50-day and 200-day moving averages, substantial price depreciation over the last 30 and 91 days, a negative profit margin, and negative earnings per share. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Exascale Labs Holdings Inc.?
- News reports highlighted positive developments including a Nasdaq listing and strategic partnerships, alongside strong revenue growth. Social media discussion was not covered in the provided notes.
- How does Market Scanner analyse Exascale Labs Holdings Inc.?
- Every analysis of Exascale Labs Holdings Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for Exascale Labs Holdings Inc.?
The bull case for XLAB centers on its recent Nasdaq listing and strategic partnerships, including a Letter of Intent with Compal for a data-center validation platform and an MOU with EnergyBank for AI compute. These developments are supported by significant year-over-year revenue growth.
What are the risks for Exascale Labs Holdings Inc.?
Risks for XLAB include the stock trading significantly below its 50-day and 200-day moving averages, substantial price depreciation over the last 30 and 91 days, a negative profit margin, and negative earnings per share.
Is Exascale Labs Holdings Inc. bullish or bearish?
Recent AI analyses of Exascale Labs Holdings Inc. examined factors on both sides. Discussed upside: The bull case for XLAB centers on its recent Nasdaq listing and strategic partnerships, including a Letter of Intent with Compal for a data-center validation platform and an MOU with EnergyBank for AI compute. These developments are supported by significant year-over-year revenue growth. Discussed risks: Risks for XLAB include the stock trading significantly below its 50-day and 200-day moving averages, substantial price depreciation over the last 30 and 91 days, a negative profit margin, and negative earnings per share. These are descriptive observations, not a recommendation.
What is the latest sentiment on Exascale Labs Holdings Inc.?
News reports highlighted positive developments including a Nasdaq listing and strategic partnerships, alongside strong revenue growth. Social media discussion was not covered in the provided notes.
How does Market Scanner analyse Exascale Labs Holdings Inc.?
Every analysis of Exascale Labs Holdings Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh XLAB.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.